Parkin coregulated gene protein is a protein that in humans is encoded by the PACRGgene.
This gene encodes a protein that is conserved across metazoans. In vertebrates, this gene is linked in a head-to-head arrangement with the adjacent parkin gene, which is associated with autosomal recessive juvenile Parkinson's disease. These genes are co-regulated in various tissues and they share a bi-directional promoter. Both genes are associated with susceptibility to leprosy. The parkin co-regulated gene protein forms a large molecular complex with chaperones, including heat shock proteins 70 and 90, and chaperonin components. This protein is also a component of Lewy bodies in Parkinson's disease patients, and it suppresses unfolded Pael receptor-induced neuronal cell death. Multiple transcript variants encoding different isoforms have been found for this gene.
Schurr E, Alcaïs A, de Léséleuc L, Abel L (2006). "Genetic predisposition to leprosy: A major gene reveals novel pathways of immunity to Mycobacterium leprae". Semin. Immunol.18 (6): 404–10. doi:10.1016/j.smim.2006.07.005. PMID16973374.
Mira MT, Alcaïs A, Van Thuc N et al. (2003). "Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population". Nat. Genet.33 (3): 412–5. doi:10.1038/ng1096. PMID12577057.
Imai Y, Soda M, Murakami T et al. (2004). "A product of the human gene adjacent to parkin is a component of Lewy bodies and suppresses Pael receptor-induced cell death". J. Biol. Chem.278 (51): 51901–10. doi:10.1074/jbc.M309655200. PMID14532270.
Ota T, Suzuki Y, Nishikawa T et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet.36 (1): 40–5. doi:10.1038/ng1285. PMID14702039.
Mira MT, Alcaïs A, Nguyen VT et al. (2004). "Susceptibility to leprosy is associated with PARK2 and PACRG". Nature427 (6975): 636–40. doi:10.1038/nature02326. PMID14737177.
Lockhart PJ, O'Farrell CA, Farrer MJ (2004). "It's a double knock-out! The quaking mouse is a spontaneous deletion of parkin and parkin co-regulated gene (PACRG)". Mov. Disord.19 (1): 101–4. doi:10.1002/mds.20000. PMID14743368.
Agirre X, Román-Gómez J, Vázquez I et al. (2006). "Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia". Int. J. Cancer118 (8): 1945–53. doi:10.1002/ijc.21584. PMID16287063.
Malhotra D, Darvishi K, Lohra M et al. (2006). "Association study of major risk single nucleotide polymorphisms in the common regulatory region of PARK2 and PACRG genes with leprosy in an Indian population". Eur. J. Hum. Genet.14 (4): 438–42. doi:10.1038/sj.ejhg.5201563. PMID16391553.
Lesage S, Magali P, Lohmann E et al. (2007). "Deletion of the parkin and PACRG gene promoter in early-onset parkinsonism". Hum. Mutat.28 (1): 27–32. doi:10.1002/humu.20436. PMID17068781.
Taylor JM, Song YJ, Huang Y et al. (2007). "Parkin Co-Regulated Gene (PACRG) is regulated by the ubiquitin-proteasomal system and is present in the pathological features of Parkinsonian diseases". Neurobiol. Dis.27 (2): 238–47. doi:10.1016/j.nbd.2007.04.014. PMID17590346.
Udina IG, Kordicheva SIu, Pospelov LE et al. (2007). "[Study of the polymorphic markers--the PARK2 and PACRG genes due to the incidence of pulmonary tuberculosis in two districts of the Republic of Tyva]". Problemy tuberkuleza i bolezneĭ legkikh (7): 27–9. PMID17722288.